Pfizer Inc
PFE
Company Profile
Business description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Contact
66 Hudson Boulevard East
New YorkNY10001-2192
USAT: +1 212 733-2323
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
88,000
Pfizer Inc News & Analysis
stocks
10 best US blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalisations look undervalued today.
stocks
5 undervalued US shares that crushed earnings
These stocks are still cheap despite impressive earnings.
stocks
3 cheap Wide Moat stocks in a divided industry
All but a couple of shares in this industry have sold off. Our analysts think these three high quality companies have fallen too far.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,652.70 | 58.30 | 0.68% |
| CAC 40 | 7,736.64 | 3.14 | 0.04% |
| DAX 40 | 20,956.41 | 33.90 | -0.16% |
| Dow JONES (US) | 43,487.83 | 334.70 | 0.78% |
| FTSE 100 | 8,531.50 | 10.96 | 0.13% |
| HKSE | 20,106.55 | 180.74 | 0.91% |
| NASDAQ | 19,630.20 | 291.91 | 1.51% |
| Nikkei 225 | 39,027.98 | 125.48 | 0.32% |
| NZX 50 Index | 13,052.90 | 35.41 | -0.27% |
| S&P 500 | 5,996.66 | 59.32 | 1.00% |
| S&P/ASX 200 | 8,402.40 | 55.00 | 0.66% |
| SSE Composite Index | 3,242.62 | 1.76 | -0.05% |